Literature DB >> 15705276

The emerging HIV/AIDS epidemic in Georgia.

Alexander Tkeshelashvili-Kessler1, Carlos del Rio, Kenrad Nelson, Tergiz Tsertsvadze.   

Abstract

The first case of HIV in Georgia was diagnosed in 1989. Through December 2002, a total of 375 cases of HIV infection were reported. However, the World Health Organization estimates that the true number of infections may be closer to 1700. In all, 70% of reported cases are among injection drug users. Based on the UNAIDS classification, Georgia is a 'low-level HIV country' with an HIV prevalence of less than 1% in all groups, including drug users. However, there is a high prevalence of hepatitis B and C, suggesting a significant risk for the spread of HIV. Georgia, a newly independent republic, is experiencing an increase in injection drug use, a rise in sexually transmitted infections and commercial sex trade that create a fertile soil for the potential rapid spread of HIV. However, it is also a country with a unique window of opportunity for limiting the spread of HIV.

Entities:  

Mesh:

Year:  2005        PMID: 15705276     DOI: 10.1258/0956462052932683

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  8 in total

1.  Prevalence of hepatitis C, HIV, and risk behaviors for blood-borne infections: a population-based survey of the adult population of T'bilisi, Republic of Georgia.

Authors:  Ketevan Stvilia; Tengiz Tsertsvadze; Lali Sharvadze; Malvina Aladashvili; Carlos del Rio; Mark H Kuniholm; Kenrad E Nelson
Journal:  J Urban Health       Date:  2006-03       Impact factor: 3.671

2.  Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia: behavioral treatment + naltrexone compared to usual care.

Authors:  David Otiashvili; Irma Kirtadze; Kevin E O'Grady; Hendrée E Jones
Journal:  Drug Alcohol Depend       Date:  2011-07-13       Impact factor: 4.492

3.  Behavioral treatment + naltrexone reduces drug use and legal problems in the Republic of Georgia.

Authors:  Irma Kirtadze; David Otiashvili; Kevin E O'Grady; Hendrée E Jones
Journal:  Am J Drug Alcohol Abuse       Date:  2012-01-05       Impact factor: 3.829

4.  Risk factors for hepatitis C virus infection among blood donors in Georgia.

Authors:  Nickolas Zaller; Kenrad E Nelson; Malvina Aladashvili; Nino Badridze; Carlos del Rio; Tengiz Tsertsvadze
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

5.  Secrecy and risk among MSM in Tbilisi, Georgia.

Authors:  Elizabeth C Costenbader; David Otiashvili; William Meyer; William A Zule; Alex Orr; Irma Kirtadze
Journal:  AIDS Care       Date:  2009-05

6.  Not all injection drug users are created equal: heterogeneity of HIV, hepatitis C virus, and hepatitis B virus infection in Georgia.

Authors:  Mark H Kuniholm; Malvina Aladashvili; Carlos Del Rio; Ketavan Stvilia; Nino Gabelia; Rohit A Chitale; Tengiz Tsertsvadze; Kenrad E Nelson
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

7.  Risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patients.

Authors:  Mark H Kuniholm; Jennifer Mark; Malvina Aladashvili; N Shubladze; G Khechinashvili; Tengiz Tsertsvadze; Carlos del Rio; Kenrad E Nelson
Journal:  Int J Infect Dis       Date:  2007-07-23       Impact factor: 3.623

8.  Burden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the community.

Authors:  Lyuba Azbel; Jeffrey A Wickersham; Yevgeny Grishaev; Sergey Dvoryak; Frederick L Altice
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.